News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Kathleen M. Fox, PhD, MPH

Articles by Kathleen M. Fox, PhD, MPH

Effectiveness and Cost-effectiveness of Rosuvastatin, Atorvastatin, and Simvastatin Among High-Risk Patients in Usual Clinical Practice

ByRobert L. Ohsfeldt, PhD,Sanjay K. Gandhi, PhD,Kathleen M. Fox, PhD, MPH,Thomas a. Stacy, PharmD,James M. McKenney, PharmD

November 1st 2006

Latest Updated Articles

Effectiveness and Cost-effectiveness of Rosuvastatin, Atorvastatin, and Simvastatin Among High-Risk Patients in Usual Clinical Practice
Published: November 1st 2006 | Updated:

Trending on AJMC

FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss

Top 5 Most-Read CLL Articles of 2025

Top 5 Most-Read "5 Things" Articles of 2025

Sleep Apnea Risk Tied to 40% Higher Odds of Poor Mental Health

Visibility, Not Lesion Burden, Drives Distress in Alopecia Areata

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.